TABLE 3.
Univariate linear regression and multivariate linear regression for the association between urinary sodium excretion and blood pressure in CKD patients
Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
β | 95% CI | p | β | 95% CI | p | |
SBP | 0.046 | 0.025–0.067 | ˂.001 | 0.020 | 0.000–0.039 | .049 |
DBP | 0.029 | 0.014–0.043 | ˂.001 | 0.015 | 0.001–0.029 | .040 |
MAP | 0.035 | 0.019–0.050 | ˂.001 | 0.016 | 0.002–0.031 | .025 |
Model 1: unadjusted.
Model 2: adjusted for age, gender, BMI, eGFR, urinary protein excretion, history of antihypertensive drug.
A two‐tailed p < .05 was considered statistically significant.
Abbreviations: BMI, body mass index; CKD, chronic kidney disease; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate.; MAP, mean arterial pressure; SBP, systolic blood pressure.